HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Breast Cancer Update
00:00
Which investigational ADCs and trials are promising for TNBC?
Dr Huppert lists ongoing trials at UCSF including EMILY, TBCRC‑047, and combinations of ADCs with immunotherapies.
Play episode from 26:14
Transcript
